WeRide Inc. — Board/Management Information 2004

Aug 2, 2004

FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED

(Incorporated in Cayman Islands with limited liability)

(Stock code: 399)

CHANGES IN DIRECTORSHIP

The board (“Board”) of directors (the “Directors”) of Far East Pharmaceutical Technology Company Limited (the “Company”) announces that Mr. Yu Er Feng (“Mr. Yu”) has tendered his notice of resignation as independent non-executive Director due to health reasons with effect from 26 June 2004. The Board announces that Mr. Chen Wei (“Mr. Chen”) and Ms. Shen Ye (“Ms. Shen”) have tendered their notices of their resignation due to personal reasons as executive Directors with effect from 30 July 2004. Mr. Yu, Mr. Chen and Ms. Shen have confirmed that there is no disagreement with the Board and there is no matter relating to their resignation that needs to be brought to the attention of the shareholders or creditors of the Company or the Stock Exchange of Hong Kong Limited (the “Stock Exchange”). The Board would like to express sincere gratitude to Mr. Yu, Mr. Chen, and Ms. Shen for their valuable contributions to the Company.

The Board is pleased to announce that Mr. Hung Chen, Richael (“Mr. Hung”) has been appointed as executive director and group managing director with effect from 30 July, 2004. Mr. Hung, aged 49, has over 23 years of experience in management and investments in Hong Kong and the mainland. Mr. Hung served as the chairman of China Investment Fund, a company listed in the Stock Exchange, between 6 December 2001 and 16 December 2002. The tenure of service contract of Mr. Hung is for a period of three years. The monthly salary of Mr. Hung is HK$86,000 plus a discretionary bonus. The salary is determined with reference to the level of salary for executives of similar position in the Company. The bonus is determined at the discretion of the Board and with reference to his performance. Mr. Hung is independent of and not connected with the Directors, chief executive and substantial shareholder of the Company or its subsidiaries or an associate of any of them. As at the date of this announcement, Mr. Hung is the beneficial owner of 17,924,000 shares of the Company.

1 FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED – Announcement

2 August 2004

As at the date of this announcement, there are four executive Directors, namely Mr. Cai Chong Zhen, Mr. Chen Ching Kon, Mr. Cai Chong Yi, and Mr. Hung Chen, and one independent non-executive Directors, namely Ms. Hu Ling Po.

By order of the board of

Far East Pharmaceutical Technology Company Limited Mr. Hung Chen, Richael

Executive Director

Hong Kong, 2 August 2004

Please also refer to the published version of this announcement in China Daily.

2

FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED – Announcement

2 August 2004